BCRX vs MNDY · rev $874.8M vs P/E 32, rev $1.23B
BioCryst Pharmaceuticals Inc (BCRX) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. BCRX currently screens at market cap $1.83B.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
BCRX currently screens at market cap $1.83B. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the BCRX and MNDY stock pages for the full models.
Not investment advice.